DHI vs ORGO · P/E 9.6, rev $34.25B vs rev $81.0M
DR Horton Inc (DHI) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the DHI and ORGO stock pages for the full models.
Not investment advice.